From: Insights into the natural history of metachromatic leukodystrophy from interviews with caregivers
Late-infantile MLD (n = 16) c | Juvenile MLD (n = 16) c | |
---|---|---|
Type of symptoma or functional lossb experienced pre-diagnosis | ||
Gross motor function, n (%) | 15 (93.8) | 9 (56.3) |
Fine motor or related function, n (%) | 10 (62.5) | 7 (43.8) |
Cognitive function, n (%) | 1 (6.3) | 11 (68.8) |
Speech, n (%) | 7 (43.8) | 3 (18.8) |
Social and/or behavioural function, n (%) | 4 (25.0) | 10 (62.5) |
Other, n (%) | 9 (56.3) | 10 (62.5) |
Types of symptoma or functional lossb experienced at any time | ||
Any gross motor function loss, n (%) | 15 (93.8) | 12 (75.0) |
Walking impairments, n (%) | ||
Independent walking never developed | 11 (68.8) | 0 (0.0) |
Walking partially lost | 1 (6.3) | 4 (25.0) |
Walking completely lost | 4 (25.0) | 7 (43.8) |
Any fine motor or related function loss, n (%) | 15 (93.8) | 12 (75.0) |
Cognitive impairment, n (%) | 6 (37.5) | 15 (93.8) |
Speech loss, n (%) | 15 (93.8) | 8 (50.0) |
Social and/or behavioural impairment, n (%) | 4 (25.0) | 15 (93.8) |
Seizures, n (%) | 7 (43.8) | 9 (56.3) |
Pain (nerve or muscle spasms), n (%) | 13 (81.3) | 6 (37.5) |
Spasticity and/or muscle spasms, n (%) | 13 (81.3) | 11 (68.8) |
Incontinence or wearing diapers, n (%) | 12 (75.0) | 10 (62.5) |